|
1
|
Pischon T, Boeing H, Hoffmann K, et al:
General and abdominal adiposity and risk of death in Europe. N Engl
J Med. 359:2105–2120. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tumova S, Woods A and Couchman JR: Heparan
sulfate proteoglycans on the cell surface: versatile coordinators
of cellular functions. Int J Biochem Cell Biol. 32:269–288. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fico A, Maina F and Dono R: Fine-tuning of
cell signaling by glypicans. Cell Mol Life Sci. 68:923–929. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li H, Melford K, Judson A and Bensadoun A:
Murine glypican-4 gene structure and expression; Sp1 and Sp3 play a
major role in glypican-4 expression in 3T3-F442A cells. Biochim
Biophys Acta. 1679:141–155. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gesta S, Blüher M, Yamamoto Y, et al:
Evidence for a role of developmental genes in the origin of obesity
and body fat distribution. Proc Natl Acad Sci USA. 103:6676–6681.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu L, Liu HM, Gu HL, et al: Effect of low
dose di-2-ethylhexylphthalate exposure on fat distribution of
offspring mice in pregnant mice. J Southeast Univ (Med Sci Edi).
33:147–150. 2014.(In Chinese).
|
|
7
|
Smith SR, De Jonge L, Volaufova J, et al:
Effect of pioglitazone on body composition and energy expenditure:
a randomized controlled trial. Metabolism. 54:24–32. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Adams M, Montague CT, Prins JB, et al:
Activators of peroxisome proliferator-activated receptor gamma have
depot-specific effects on human preadipocyte differentiation. J
Clin Invest. 100:3149–3153. 1997. View Article : Google Scholar
|
|
9
|
Kang JG, Park CY, Ihm SH, et al:
Mechanisms of adipose tissue redistribution with rosiglitazone
treatment in various adipose depots. Metabolism. 59:46–53. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Laplante M, Festuccia WT, Soucy G, et al:
Mechanisms of the depot specificity of peroxisome
proliferator-activated receptor gamma action on adipose tissue
metabolism. Diabetes. 55:2771–2778. 2006. View Article : Google Scholar
|
|
11
|
Laplante M, Sell H, MacNaul KL, et al:
PPAR-gamma activation mediates adipose depot-specific effects on
gene expression and lipoprotein lipase activity: mechanisms for
modulation of postprandial lipemia and differential adipose
accretion. Diabetes. 52:291–299. 2003. View Article : Google Scholar
|
|
12
|
Ma LJ, Mao SL, Taylor KL, et al:
Prevention of obesity and insulin resistance in mice lacking
plasminogen activator inhibitor 1. Diabetes. 53:336–346. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kuda O, Stankova B, Tvrzicka E, et al:
Prominent role of liver in elevated plasma palmitoleate levels in
response to rosiglitazone in mice fed high-fat diet. J Physiol
Pharmacol. 60:135–140. 2009.PubMed/NCBI
|
|
14
|
Liu L, Gu H, Yang J, et al: Adipogenic
differentiation is not influenced by lentivirus-mediated shRNA
targeting the SOCS3 gene in adipose-derived stromal cells. Mol Biol
Rep. 37:2455–2462. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
|
|
16
|
Scion image software version 4.0.
http://www.bbioo.com/download/58-196-1.htmluri.
Accessed March 26, 2008
|
|
17
|
Hsu WH, Lee BH, Hsu YW and Pan TM:
Peroxisome proliferator-activated receptor-γ activators monascin
and rosiglitazone attenuate carboxymethyllysine-induced fibrosis in
hepatic stellate cells through regulating the oxidative stress
pathway but independent of the receptor for advanced glycation end
products signaling. J Agric Food Chem. 61:6873–6879. 2013.
|
|
18
|
Chappard D, Marchand-Libouban H, Moreau MF
and Baslé MF: Thiazolidinediones cause compaction of nuclear
heterochromatin in the pluripotent mesenchymal cell line C3H10T1/2
when inducing an adipogenic phenotype. Anal Quant Cytopathol
Histopathol. 35:85–94. 2013.PubMed/NCBI
|
|
19
|
Day C: Thiazolidinediones: a new class of
antidiabetic drugs. Diabet Med. 16:179–192. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fonseca V: Effect of thiazolidinediones on
body weight in patients with diabetes mellitus. Am J Med. 115 Suppl
8A:42S–48S. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takasawa K, Kubota N, Terauchi Y and
Kadowaki T: Impact of increased PPARgamma activity in adipocytes in
vivo on adiposity, insulin sensitivity and the effects of
rosiglitazone treatment. Endocr J. 55:767–776. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van Harmelen V, Dicker A, Rydén M, et al:
Increased lipolysis and decreased leptin production by human
omental as compared with subcutaneous preadipocytes. Diabetes.
51:2029–2036. 2002.PubMed/NCBI
|
|
23
|
Ussar S, Bezy O, Blüher M and Kahn CR:
Glypican-4 enhances insulin signaling via interaction with the
insulin receptor and serves as a novel adipokine. Diabetes.
61:2289–2298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoo HJ, Hwang SY, Cho GJ, et al:
Association of glypican-4 with body fat distribution, insulin
resistance, and nonalcoholic fatty liver disease. J Clin Endocrinol
Metab. 98:2897–2901. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sassa Y, Hata Y, Aiello LP, et al:
Bifunctional properties of peroxisome proliferator-activated
receptor gamma1 in KDR gene regulation mediated via interaction
with both Sp1 and Sp3. Diabetes. 53:1222–1229. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sugawara A, Uruno A, Kudo M, et al:
Transcription suppression of thromboxane receptor gene by
peroxisome proliferator-activated receptor-gamma via an interaction
with Sp1 in vascular smooth muscle cells. J Biol Chem.
277:9676–9683. 2002. View Article : Google Scholar
|
|
27
|
Chung SS, Choi HH, Cho YM, Lee HK and Park
KS: Sp1 mediates repression of the resistin gene by PPARgamma
agonists in 3T3-L1 adipocytes. Biochem Biophys Res Commun.
348:253–258. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chung SS, Kim JH, Park HS, et al:
Activation of PPARgamma negatively regulates O-GlcNAcylation of
Sp1. Biochem Biophys Res Commun. 372:713–718. 2008. View Article : Google Scholar : PubMed/NCBI
|
